Last reviewed · How we verify
Antibiotics only — Competitive Intelligence Brief
marketed
Antibiotic (broad class)
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Antibiotics only (Antibiotics only) — George Washington University. Antibiotics kill or inhibit bacterial pathogens through various mechanisms including cell wall disruption, protein synthesis inhibition, or DNA damage.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Antibiotics only TARGET | Antibiotics only | George Washington University | marketed | Antibiotic (broad class) | ||
| Antibiotics administration | Antibiotics administration | The Central and Eastern European Gynecologic Oncology Group | marketed | Antibiotic (broad class) | ||
| Standard Antibiotic Treatment | Standard Antibiotic Treatment | Dr Hamail Khanum | marketed | Antibiotic (broad class) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antibiotic (broad class) class)
- Dr Hamail Khanum · 1 drug in this class
- George Washington University · 1 drug in this class
- The Central and Eastern European Gynecologic Oncology Group · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Antibiotics only CI watch — RSS
- Antibiotics only CI watch — Atom
- Antibiotics only CI watch — JSON
- Antibiotics only alone — RSS
- Whole Antibiotic (broad class) class — RSS
Cite this brief
Drug Landscape (2026). Antibiotics only — Competitive Intelligence Brief. https://druglandscape.com/ci/antibiotics-only. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab